Clinical Trial Update: A Phase 1, Open-label Study to Investigate the Pharmacokinetics of Tralokinumab (CAT-354) in Adolescents With Asthma [Phase 1]

View source ↗

Summary

A Phase 1, open-label pharmacokinetic study of tralokinumab (CAT-354) in adolescents with asthma has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: MedImmune LLC | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2017-01-20